Envoy Medical
COCH
88 hedge funds and large institutions have $335M invested in Envoy Medical in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 5 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
4% more funds holding
Funds holding: 85 → 88 (+3)
2.37% more ownership
Funds ownership: 78.1% → 80.48% (+2.4%)
3% more capital invested
Capital invested by funds: $325M → $335M (+$10.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
+$3.77M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.11M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.11M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.61M |
| 5 |
SCM
Saba Capital Management
New York
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EH
EMG Holdings
Old Greenwich,
Connecticut
|
-$2.18M |
| 2 |
AC
Athanor Capital
New York
|
-$1.7M |
| 3 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$551K |
| 4 |
JP Morgan Chase
New York
|
-$452K |
| 5 |
GH
GAM Holding
Zurich,
Switzerland
|
-$397K |
COCH Hedge Fund Activity: Q2 2022 in Review
88 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2022, worth a combined $335M — up 3.3% from $325M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new COCH positions and 5 closed out — a net gain of 3 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Parallax Volatility Advisers, opening a new position worth an estimated $3.77M. The largest seller was EMG Holdings, exiting entirely with an estimated $2.18M sold.
- 88 institutional investors held Envoy Medical (COCH) as of Q2 2022, up from 85 in Q1 2022.
- Funds reported $335M of Envoy Medical stock for Q2 2022, up 3.3% quarter-over-quarter.
- 8 funds opened new Envoy Medical positions in Q2 2022 and 5 closed out, a net change of +3 holders.
- The largest Envoy Medical buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $3.77M added.
- The largest Envoy Medical seller in Q2 2022 was EMG Holdings, an estimated $2.18M sold.
Based on aggregated 13F filings for Q2 2022.